PRESS RELEASE published on 11/03/2023 at 16:19, 3 years ago Form 8.3 - Apex Fundrock Limited : Re Equals Group plc
PRESS RELEASE published on 11/01/2023 at 16:43, 3 years ago Form 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
PRESS RELEASE published on 10/04/2023 at 14:39, 3 years 1 month ago Form 8.3 - Apex Fundrock Limited : Re Blancco Technology Group Plc
PRESS RELEASE published on 09/07/2023 at 17:09, 3 years 1 month ago Form 8.3 - Apex Fundrock Limited : Re Curtis Banks Group plc - AMENDMENT
PRESS RELEASE published on 09/07/2023 at 15:56, 3 years 1 month ago Form 8.3 - Apex Fundrock Limited : Re Curtis Banks Group plc
PRESS RELEASE published on 08/03/2023 at 16:20, 3 years 3 months ago Form 8.3 - Apex Fundrock Limited :
Published on 11/04/2026 at 23:10, 4 hours 54 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 5 hours 4 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 49 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 5 hours 59 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 03:55, 9 minutes ago AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Published on 11/05/2026 at 03:10, 54 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 4 hours 1 minute ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 8 hours 23 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 8 hours 39 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:00, 10 hours 4 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 10 hours 4 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 10 hours 20 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
